Skip to main content
SpringerLink
Log in

Historical Perspective

  • Chapter
Implantable Cardioverter-Defibrillator

  • 92 Accesses

Abstract

Initially, the idea of having an implanted device that would automatically deliver an electrical shock was considered unconventional, too extreme and undesirable. The concept was looked upon with some degree of disbelieve and its future was greatly doubted. In spite of such skepticism, the implantable defibrillator found a definite role in medicine, although its application was initially limited to those patients with recurrent cardiac arrest that are refractory to other forms of therapy. In such patients, the physician would have no choice because other forms of treatment have been exhausted. Undoubtedly, in following such algorithm, some patients would have died from their arrhythmia and never benefited from the device therapy. In that respect, sudden death from ventricular arrhythmia was common and, to some degree, an acceptable outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mirowski D. Personal comments written about Michel Mirowski on behalf of the family. Pacing Clin Electrophysiol, 1991; 14 (5 Pt 2): 872.

    Article  PubMed  CAS  Google Scholar 

  2. Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator. An approach to prevention of sudden coronary death. Arch Intern Med, 1970; 126 (1): 158–161.

    Article  PubMed  CAS  Google Scholar 

  3. Mirowski M, Mower MM, and Mendeloff AI. Implanted standby defibrillators. Circulation, 1973; 47 (5): 1135–1136.

    Article  PubMed  CAS  Google Scholar 

  4. Mirowski M, Mower MM, Gott VL, et al. Feasibility and effectiveness of low-energy catheter defibrillation in man, Circulation, 1973; 47 (1): 79–85.

    Article  PubMed  CAS  Google Scholar 

  5. Mirowski M, Mower MM, Staewen WS, et al. Automatic defibrillation. Jama, 1971; 217 (7): 964.

    Article  PubMed  CAS  Google Scholar 

  6. Cobb LA, Baum RS, Alvarez Hd, et al. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation, 1975;52(6 Suppl):111 223–235.

    Google Scholar 

  7. Schaffer WA and Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl.J Med, 1975; 293 (6): 259–262.

    Article  CAS  Google Scholar 

  8. Graboys TB, Lown B, Podrid PJ, et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol, 1982; 50 (3): 437–443.

    Article  PubMed  CAS  Google Scholar 

  9. Gillum RF. Sudden coronary death in the United States: 1980–1985. Circulation, 1989; 79 (4): 756–765.

    Article  PubMed  CAS  Google Scholar 

  10. Langer A, Heilman MS, Mower MM, et al. Considerations in the development of the automatic implantable defibrillator. Med Instrum, 1976; 10 (3): 163–167.

    PubMed  CAS  Google Scholar 

  11. Mirowski M and Mower MM. Transvenous automatic defibrillator as an approach to prevention of sudden death from ventricular fibrillation. Heart Lung, 1973; 2 (6): 867–869.

    PubMed  CAS  Google Scholar 

  12. Mirowski M, Mower MM, Langer A, et al. A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation. Circulation, 1978; 58 (1): 90–94.

    Article  PubMed  CAS  Google Scholar 

  13. Stack JM, Houston C, Mirowski M, et al. Automatic implantable defibrillator for the patient with recurrent refractory malignant ventricular arrhythmias: case report. Heart Lung, 1982;11(6):512–5I5.

    PubMed  CAS  Google Scholar 

  14. Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med, 1983; 98 (5 Pt 1): 585–588.

    PubMed  CAS  Google Scholar 

  15. Mirowski M, Reid PR, Mower MM, et al. Clinical performance of the implantable cardioverterdefibrillator. Pacing Clin Electrophysiol, 1984; 7 (6 Pt 2): 1345–1350.

    Article  PubMed  CAS  Google Scholar 

  16. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol, 1989; 13 (6): 1353–1361.

    Article  PubMed  CAS  Google Scholar 

  17. Fogoros RN, Elson JJ, Bonnet CA, et al. Efficacy of the automatic implantable cardioverterdefibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol, 1990; 16 (2): 381–386.

    Article  PubMed  CAS  Google Scholar 

  18. Cohen TJ, Reid PR, Mower MM, et al. The automatic implantable cardioverter-defibrillator. Longterm clinical experience and outcome at a hospital without an open-heart surgery program. Arch Intern Med, 1992;152(1):65–69.

    Google Scholar 

  19. Vaughan Williams EM. Quantitative assessment of antidysrhythmic drugs. G Ital Cardiol, 1972; 2 (1): 157.

    Google Scholar 

  20. Vaughan Williams EM. Subgroups of class 1 antiarrhythmic drugs. Eur Heart J, 1984; 5 (2): 96–98.

    Google Scholar 

  21. Vaughan Williams EM. Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial [see comments]. J Clin Pharmacol, 1991; 31 (2): 123–135.

    Google Scholar 

  22. Lown B. Management of patients at high risk of sudden death. Am Heart J, 1982;103(4 Pt 2):689–697.

    Google Scholar 

  23. Lown B, Podrid PJ, De Silva RA, et al. Sudden cardiac death-management of the patient at risk. Curr Probl Cardiol, 1980; 4 (12): 1–62.

    Article  PubMed  CAS  Google Scholar 

  24. Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. I. Mechanisms. Circulation, 1978; 57 (3): 431–440.

    Article  CAS  Google Scholar 

  25. Horowitz LN, Josephson ME, Farshidi A, et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation, 1978; 58 (6): 986–997.

    Article  PubMed  CAS  Google Scholar 

  26. Horowitz LN, Vetter VL, Harken AH, et al. Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot. Am J Cardiol, 1980; 46 (3): 446–452.

    Article  PubMed  CAS  Google Scholar 

  27. Denes P, Wu D, Dhingra RC, et al. Electrophysiological studies in patients with chronic recurrent ventricular tachycardia. Circulation, 1976; 54 (2): 229–236.

    Article  PubMed  CAS  Google Scholar 

  28. Fontaine G, Guiraudon G, Frank R, et al. Modem concepts of ventricular tachycardia. The value of electrocardiological investigations and delayed potentials in ventricular tachycardia of ischemic and nonischemic etiology (31 operated cases). Eur J Cardiol, 1978; 8 (4–5): 565–580.

    PubMed  CAS  Google Scholar 

  29. Josephson ME and Horowitz LN. Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia. Am J Cardiol, 1979; 43 (3): 631–642.

    Article  PubMed  CAS  Google Scholar 

  30. Josephson ME, Kastor JA, and Horowitz LN. Electrophysiologic management of recurrent ventricular tachycardia in acute and chronic ischemic heart disease. Cardiovasc Clin, 1980; 11 (1): 35–55.

    PubMed  CAS  Google Scholar 

  31. Garan H and Ruskin JN. Localized reentry. Mechanism of induced sustained ventricular tachycardia in canine model of recent myocardial infarction. J Clin Invest, 1984; 74 (2): 377–392.

    Article  PubMed  CAS  Google Scholar 

  32. Gillis AM, Winkle RA, and Echt DS. Role of extrastimulus prematurity and intraventricular conduction time in inducing ventricular tachycardia or ventricular fibrillation secondary to coronary artery disease. Am J Cardiol, 1987; 60 (7): 590–595.

    Article  PubMed  CAS  Google Scholar 

  33. Hammill SC, Sugrue DD, Gersh BI, et al. Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses. Mayo Clin Proc, 1986; 61 (6): 478–503.

    Article  PubMed  CAS  Google Scholar 

  34. Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 4. Pleomorphism. Circulation, 1979; 59 (3): 459–468.

    Article  CAS  Google Scholar 

  35. Spielman SR, Farshidi A, Horowitz LN, et al. Ventricular fibrillation during programmed ventricular stimulation: incidence and clinical implications. Am J Cardiol, 1978; 42 (6): 913–918.

    Article  PubMed  CAS  Google Scholar 

  36. Morady F, Hess D, and Scheinman MM. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site. Am J Cardiol, 1982; 50 (5): 1055–1060.

    Article  PubMed  CAS  Google Scholar 

  37. Stevenson WG, Wiener I, and Weiss JN. Comparison of bipolar and unipolar programmed electrical stimulation for the initiation of ventricular arrhythmias: significance of anodal excitation during bipolar stimulation. Circulation, 1986; 73 (4): 693–700.

    Article  PubMed  CAS  Google Scholar 

  38. Stevenson WG, Weiss J, and Oye RK. Selecting therapy for sustained ventricular tachycardias: importance of the sensitivity and specificity of programmed electrical stimulation for predicting arrhythmia recurrences. Am Heart J, 1990; 119 (4): 871–877.

    Article  PubMed  CAS  Google Scholar 

  39. Michelson EL, Spielman SR, Greenspan AM, et al. Electrophysiologic study of the left ventricle: indications and safety. Chest, 1979; 75 (5): 592–596.

    Article  PubMed  CAS  Google Scholar 

  40. Farshidi A, Michelson EL, Greenspan AM, et al. Repetitive responses to ventricular extrastimuli: incidence, mechanism, and significance. Am Heart 1, 1980; 100 (1): 59–68.

    Article  CAS  Google Scholar 

  41. Vandepol CJ, Farshidi A, Spielman SR, et al. Incidence and clinical significance of induced ventricular tachycardia. Am J Cardiol, 1980; 45 (4): 725–731.

    Article  PubMed  CAS  Google Scholar 

  42. Cooper MJ, Hunt LJ, Palmer KJ, et al. Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation. J Am Coll Cardiol, 1988; 11 (1): 101–108.

    Article  PubMed  CAS  Google Scholar 

  43. Hummel JD, Strickberger SA, Daoud E, et al. Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli. Circulation, 1994; 90 (6): 2827–2832.

    Article  PubMed  CAS  Google Scholar 

  44. Morady F, Dicarlo LA, Jr., Liem LB, et al. Effects of high stimulation current on the induction of ventricular tachycardia. Am J Cardiol, 1985; 56 (1): 73–78.

    Article  PubMed  CAS  Google Scholar 

  45. Cua M and Veltri EP. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current. Pacing Clin Electrophysiol, 1993; 16 (3 Pt 1): 382–386.

    Article  PubMed  CAS  Google Scholar 

  46. Breithardt G, Seipel L, Abendroth RR, et al. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia. Eur Heart J, 1980; 1 (1): 11–24.

    PubMed  CAS  Google Scholar 

  47. Morady F, Scheinman MM, Hess DS, et al. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. Am J Cardiol, 1983; 51(1):85–89

    Article  PubMed  CAS  Google Scholar 

  48. Swerdlow CD, Winkle RA, and Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med, 1983; 308 (24): 1436–1442.

    Article  PubMed  CAS  Google Scholar 

  49. Liem LB and Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am. J Cardiol, 1988; 62 (9): 611–616.

    Article  PubMed  CAS  Google Scholar 

  50. Liberthson RR, Nagel EL, Hirschman JC, et al. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation, 1974; 49 (5): 790–798.

    Article  PubMed  CAS  Google Scholar 

  51. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators. Circulation, 1989; 79 (6): 1354–1360.

    Article  Google Scholar 

  52. Biblo LA, Carlson MD, and Waldo AL. Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy. J Am Coll Cardiol, 1995; 25 (7): 1601–1604.

    Article  PubMed  CAS  Google Scholar 

  53. Mason JW, Marcus FI, Bigger JT, et al. A summary and assessment of the findings and conclusions of the ESVEM trial. Prog Cardiovasc Dis, 1996; 38 (5): 347–358.

    Article  PubMed  CAS  Google Scholar 

  54. Reiter MJ. The ESVEM trial: impact on treatment of ventricular tachyarrhythmias. Electrophysiologic Study Versus Electrocardiographic Monitoring. Pacing Clin Electrophysiol, 1997; 20 (2 Pt 2): 468–477.

    Article  PubMed  CAS  Google Scholar 

  55. Fogoros RN, Fiedler SB, and Elson JJ. Empiric amiodarone versus “ineffective” drug therapy in patients with refractory ventricular tachyarrhythmias. Pacing Clin Electrophysiol, 1988; 11 (7): 1009–1017.

    Article  PubMed  CAS  Google Scholar 

  56. Di Pede F, Raviele A, Gasparini G, et al. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. G Ital Cardiol, 1990; 20 (9): 819–827.

    PubMed  Google Scholar 

  57. Nora M and Zipes DP. Empiric use of amiodarone and sotalol. Am J Cardiol, 1993; 72 (16) 62F - 69F.

    Article  PubMed  CAS  Google Scholar 

  58. Proclemer A, Facchin D, Vanuzzo D, et al. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction. Cardiovasc Drugs Ther, 1993; 7 (4): 683–689.

    Article  PubMed  CAS  Google Scholar 

  59. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. Am J Cardiol, 1993; 72 (3): 280–287.

    Google Scholar 

  60. Greene HL. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. Am J Cardiol, 1993; 72 (16): 70F - 74F.

    Article  PubMed  CAS  Google Scholar 

  61. Dorian P, Newman D, Harris L, et al. Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone. Can J Cardiol, 1994; 10 (2): 193–200.

    PubMed  CAS  Google Scholar 

  62. Dorian P, Newman D, Sheahan R, et al. d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy. 1 Cardiovasc Electrophysiol, 1996; 7 (10): 952–961.

    Article  CAS  Google Scholar 

  63. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group [see comments]. N Engl J Med, 1999; 340 (24): 1855–1862.

    Article  PubMed  CAS  Google Scholar 

  64. Seidl K, Hauer B, Schwick NG, et al. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol, 1998; 82 (6): 744–748.

    Article  PubMed  CAS  Google Scholar 

  65. Ostermeyer J, Breithardt G, Kolvenbach R, et al. Intraoperative electrophysiologic mapping during cardiac surgery. Thorac Cardiovasc Surg, 1979; 27 (4): 260–270.

    Article  PubMed  CAS  Google Scholar 

  66. Guiraudon G, Fontaine G, Frank R, et al. [Encircling endocardial ventriculotomy in the treatment of recurrent ventricular tachycardia after myocardial infarction]. Arch Mal Coeur Vaiss, 1982; 75 (9): 1013–1021.

    PubMed  CAS  Google Scholar 

  67. Breithardt G, Seipel L, Ostermeyer 1, et al. Effects of antiarrhythmic surgery on late ventricular potentials recorded by precordial signal averaging in patients with ventricular tachycardia. Am Heart J, 1982; 104 (5 Pt 1): 996–1003.

    Article  PubMed  CAS  Google Scholar 

  68. Klein H, Frank G, Werner PC, et al. [Results of electrophysiologically guided surgery in ventricular tachycardia]. G Ital Cardiol, 1983; 13 (4): 318–322.

    PubMed  CAS  Google Scholar 

  69. Swerdlow CD, Mason JW, Stinson EB, et al. Results of operations for ventricular tachycardia in 105 patients. J Thorac Cardiovasc Surg, 1986; 92 (1): 105–113.

    PubMed  CAS  Google Scholar 

  70. Saksena S, Hussain SM, Gielchinsky I, et al. Intraoperative mapping-guided argon laser ablation of malignant ventricular tachycardia. Am J Cardiol, 1987; 59 (1): 78–83.

    Article  PubMed  CAS  Google Scholar 

  71. Nath S, Haines DE, Kron IL, et al. The long-term outcome of visually directed subendocardial resection in patients without inducible or mappable ventricular tachycardia at the time of surgery. J Cardiovasc Electrophysiol, 1994; 5 (5): 399–407.

    Article  PubMed  CAS  Google Scholar 

  72. Thakur RK, Guiraudon GM, Klein GJ, et al. Intraoperative mapping is not necessary for VT surgery. Pacing Clin Electrophysiol, 1994; 17 (11 Pt 2): 2156–2162.

    Article  PubMed  CAS  Google Scholar 

  73. Borggrefe M, Podczeck A, Ostermeyer 1, et al., Long-term results of electrophysiologically guided antitachyeardia surgery in ventricular tachyarrhythmias: A collaborative report on 665 patients,in Nonpharmacological Therapy of Tachyarrhythmias,G. Breithardt, M. Borgreffe, and D. Zipes, Editors. 1987, Futura Publishing Company: Mount Kisco, NY. p. 109–132.

    Google Scholar 

  74. Bernstein AD, Canon Ai, Fisher JD, et al. North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code. Pacing Clin Electrophysiol, 1993; 16 (9): 1776–1780.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Cardiac Electrophysiology, Stanford University Medical Center, Stanford, CA, USA

    L. Bing Liem D.O. (Director)

Authors
  1. L. Bing Liem D.O.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Liem, L.B. (2001). Historical Perspective. In: Implantable Cardioverter-Defibrillator. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1837-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-1837-0_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5627-6

  • Online ISBN: 978-94-017-1837-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation